Changes in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.
Teresa B. Gibson, PhD
Advertisement
Articles by Teresa B. Gibson, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
2
FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure
3
What Real-World Data Show About Moving Patients From Humira to Biosimilars
4
Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know
5